Reviva Pharmaceuticals Holdings, Inc. · NASDAQ:RVPH
Integrated Core Strategies (US) LLC reported a 6.20% stake in Reviva Pharmaceuticals Holdings, Inc. (Schedule 13G)
Event Mar 23, 2026 · Filed Mar 30, 2026
Integrated Core Strategies (US) LLC reported a 6.20% stake in Reviva Pharmaceuticals Holdings, Inc., 793,952 shares, as a passive investor on Mar 23, 2026. Filed Mar 30, 2026 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 793,952
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 6.20% | 793,952 |
| Millennium Management LLC | 6.20% | 793,952 |
| Millennium Group Management LLC | 6.20% | 793,952 |
| Israel A. Englander | 6.20% | 793,952 |
Source
Related
- Reviva Pharmaceuticals Holdings, Inc.
- Millennium Management LLC
- Reviva Pharmaceuticals Holdings, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Aug 3, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G/A · UBS Group AG · Jul 31, 2026
- Schedule 13G/A · CVI Investments, Inc. · May 15, 2026
- Schedule 13G · Barclays PLC · May 14, 2026
- Schedule 13G · UBS Group AG · May 7, 2026